Identification and management of patients with HFpEF and diabetes10' education - Oct. 26, 2022 - Prof. Silvio Inzucchi, MD (New Haven, CT, USA) & Prof. Pardeep Jhund, MD, PhD (Glasgow, UK)
Video navigation menu
- How to identify patients with HFpEF? 00:28
- Role of SGLT2i in heart failure 02:35
- Possible working mechanisms of SGLT2i 04:20
This discussion was part of the EBAC-accredited symposium "Is HFpEF hiding in your practice? An expert debate on the emerging role of diabetologists" held during the EASD congress 2022.
Silvio Inzucchi is Professor of Medicine at the Yale School of Medicine in New Haven, CT, USA where he serves as Clinical Chief of the Section of Endocrinology and Medical Director of the Yale Diabetes Center.
Pardeep Jhund is Professor of Cardiology and Epidemiology at the University of Glasgow and an honorary consultant cardiologist at the Queen Elizabeth University Hospital, Glasgow, UK.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca.